[go: up one dir, main page]

Sevéus et al., 1997 - Google Patents

Human neutrophil lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. Studies in bronchial and lung parenchymal tissue and peripheral …

Sevéus et al., 1997

Document ID
14863923897945832246
Author
Sevéus L
Amin K
Peterson C
Roomans G
Venge P
Publication year
Publication venue
Histochemistry and cell biology

External Links

Snippet

The neutrophilic granulocyte is a cytotoxic and potentially tissue-injuring cell participating in the destructive processes and symptoms seen in a variety of inflammatory diseases. Sensitive immunoassays have been introduced to measure the levels of specific secretory …
Continue reading at link.springer.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/574—Immunoassay; Biospecific binding assay for cancer
    • G01N33/57407—Specifically defined cancers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Similar Documents

Publication Publication Date Title
Sevéus et al. Human neutrophil lipocalin (HNL) is a specific granule constituent of the neutrophil granulocyte. Studies in bronchial and lung parenchymal tissue and peripheral blood cells
EP0756708B1 (en) Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation
Sur et al. Localization of eosinophil‐derived neurotoxin and eosinophil cationic protein in neutrophilic leukocytes
Rooney et al. GPI-anchored complement regulatory proteins in seminal plasma. An analysis of their physical condition and the mechanisms of their binding to exogenous cells.
George et al. Demonstration of Rickettsia conorii-induced endothelial injury in vivo by measuring circulating endothelial cells, thrombomodulin, and von Willebrand factor in patients with Mediterranean spotted fever [see comments]
Höchsmann et al. Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes
EP2280279B1 (en) Method for evaluation of function of phagocyte
US7122322B2 (en) Endometriosis-specific secretory protein
US7534571B2 (en) Diagnostic and prognostic compounds and method
US20110003304A1 (en) Method and kit for detection of autoimmune chronic urticaria
JP2013539856A (en) Method for diagnosis and / or prognosis of inflammatory condition
Sato et al. Applicability of Nanotrap Sg as a semen detection kit before male-specific DNA profiling in sexual assaults
Oda et al. Clinicopathological significance of intratubular giant macrophages in progressive glomerulonephritis
KR20140093901A (en) A Biomarker for Diagnosing Rheumatoid Arthritis
Hancock et al. Immunohistological studies with A1-3, a monoclonal antibody to activated human monocytes and macrophages.
EP0447490B1 (en) Detection of basement membrane components as diagnostic of cancer and other diseases
Brenes et al. PLP fixation for combined routine histology and immunocytochemistry of liver biopsies
Lee et al. Lectins as markers for eosinophilic leukocytes
Ugele et al. Binding of Human IgG and F (ab′) 2and Fc Fragments to Cultured Trophoblast Cells from Human Term Placenta
Paterson et al. Expression of the serpin centerin defines a germinal center phenotype in B-cell lymphomas
Takezawa et al. Assessment of differentiation in adenocarcinoma cells from pleural effusion by peripheral airway cell markers and their diagnostic values
US20020098188A1 (en) Blood coagulation factor-activating protein and antibody thereto
EP1407266B1 (en) Method for estimation of the amount of specific neutrophil cell types
US20240318262A1 (en) Biomarker for predicting prognosis of cancer patient, method for predicting prognosis of cancer patient, method for predicting effect of cancer therapeutic drug in cancer patient, and kit for predicting prognosis of cancer patient
Zeltser et al. The leukocyte adhesiveness/aggregation test as an inflammation-related, plasma-dependent agglutination phenomenon